Market revenue in 2024 | USD 8,930.0 million |
Market revenue in 2030 | USD 13,929.1 million |
Growth rate | 7.7% (CAGR from 2025 to 2030) |
Largest segment | Conventional drugs (small molecules) |
Fastest growing segment | Biologics & Biosimilars (Large Molecules) |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
Key market players worldwide | Merck & Co Inc, Roche Holding AG, Novartis AG ADR, AbbVie Inc, Johnson & Johnson, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, GSK PLC, Takeda Pharmaceutical Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 58.43% in 2024. Horizon Databook has segmented the Thailand pharmaceutical market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
Thailand’s pharmaceutical market is experiencing strong growth, driven by increasing healthcare demand, rising investments in local manufacturing, a robust medical tourism industry, and government initiatives to promote the sector.
As the country strengthens its position as a regional pharmaceutical hub, significant investments, such as ACG’s new capsule manufacturing facility in Rayong in January 2025, further support Thailand’s expanding pharmaceutical and nutraceutical industries.
A key driver of Thailand’s pharmaceutical market is its growing population and rising healthcare needs. The country is witnessing an increase in chronic diseases such as diabetes, cardiovascular diseases, and cancer, leading to a higher demand for prescription medicines, biologics, and specialty drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand pharmaceutical market , including forecasts for subscribers. This country databook contains high-level insights into Thailand pharmaceutical market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related industry reports found.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account